Kirkland & Ellis LLP

With a notable and strong track record with contentious merger clearances, both domestic and international, the antitrust and competition team at Kirkland & Ellis LLP regularly represents leading healthcare, pharma, and life sciences sector clients on the full range of contentious antitrust matters, including reverse payment cases, IP-related antitrust litigation, and monopolization claims. Recent work highlights for the team include securing a complete defense verdict for Gilead Sciences in a class action involving claims of reverse payments. Key names in the team’s Chicago office include James Mutchnik and Daniel Laytin; Mutchnik focuses on cartel-related litigation, including price-fixing and monopolization claims, while Laytin has long-standing expertise advising on the full spectrum of contentious antitrust issues. Also in Chicago is Christa Cottrell, who handles large class actions in the pharma and healthcare space. Olivia Adendorff splits her time between Dallas and Washington DC and is another name to note for class actions, while Devora Allon handles pay-for-delay cases from New York.